Actively Recruiting
ARTICE® Real Data Collection & Observational Trial, Phase 4 Study
Led by Artcline GmbH · Updated on 2026-02-09
200
Participants Needed
1
Research Sites
113 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The objectives of this registry study are to: 1. Record real-life data related to the use of the ARTICE® therapy in sepsis subjects. 2. Further evaluate ARTICE® treatment efficacy. 3. Identify potential sub-groups, assess their risk-benefit- and safety profile. 4. Changes in SOFA score D0 to SOFA Score D7.
CONDITIONS
Official Title
ARTICE® Real Data Collection & Observational Trial, Phase 4 Study
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Subjects 18 years or older who are planned to receive ARTICE4 treatment during their ICU stay
You will not qualify if you...
History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Klinikum Magdeburg, Klinik für Intensiv- und Rettungsmedizin
Magdeburg, Germany, 39130
Actively Recruiting
Research Team
J
Jens Altrichter, Dr. med.
CONTACT
J
Judith Gross, M. Sc.
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here